🔗 Permalink

Inventor profile of:

Elisabetta Bianchi

City:

Rome

Country:

Italy

Published Applications:

Last publication date:

2026-04-30

Top Assignees for applications by Elisabetta Bianchi

The entities that hold a legal rights for patent applications filed by inventor Bianchi Elisabetta:

Merck Sharp & Dohme LLC 7 Rahway, NJ United States
Ra Pharmaceuticals, Inc. 4 Cambridge, MA United States
Merck Sharp Dohme Corp. 4 Rahway, NJ United States
Istituto di Ricerche di Biologia Molecolare P. Angeletti SpA 2 Rome, Italy
Istituto di Ricerche di Biologia Molecolare P. Angeletti S.r.l. 2 Rome (RM), Italy
Merck Sharp & Dohme LLC 1 Rahway, NJ United States
Istituto Di Ricerche Di Biologia Molecolare P. Angeletti S.p.A. 1 Pomezia (Roma), Italy
ISTITUTO DI RICERCHE DI BIOLOGIA MOLECOLARE P. ANGELETTI SPA 1 POMEZIA, Italy

Recent patent applications by Bianchi Elisabetta

Elisabetta Bianchi from Rome, IT has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2026-04-30

US20260116923A1

Chemistry; metallurgy

CYCLIC PEPTIDE IL-1BETA TRAP FOR THE TREATMENT OF ATHEROSCLEROSIS AND INFLAMMATORY DISORDERS

#2 | 2025-09-25

US20250296959A1

Chemistry; metallurgy

B7-H3 TARGETING PEPTIDES AND CONSTRUCTS THEREOF

#3 | 2025-06-26

US20250206781A1

Chemistry; metallurgy

PCSK9 ANTAGONIST COMPOUNDS

#4 | 2023-12-21

US20230406885A1

Chemistry; metallurgy

CYCLIC PEPTIDES FOR TRAPPING INTERLEUKIN-1 BETA

#5 | 2023-09-28

US20230303625A1

Chemistry; metallurgy

Cyclic polypeptides for PCSK9 inhibition

#6 | 2023-05-25

US20230159592A1

Chemistry; metallurgy

PCSK9 antagonist compounds

#7 | 2023-04-20

US20230122330A1

Chemistry; metallurgy

Cyclic polypeptides for PCSK9 inhibition

#8 | 2021-09-16

US20210284694A1

Chemistry; metallurgy

Cyclic polypeptides for PCSK9 inhibition

#9 | 2021-07-15

US20210214395A1

Chemistry; metallurgy

PCSK9 antagonists bicyclo-compounds

#10 | 2021-06-03

US20210163538A1

Chemistry; metallurgy

Cyclic polypeptides for PCSK9 inhibition

#11 | 2019-12-26

US20190389909A1

Chemistry; metallurgy

PCSK9 antagonist compounds

#12 | 2014-04-03

US20140094405A1

Chemistry; metallurgy

CHOLESTEROL DERIVATIVES OF INHIBITORS OF VIRAL FUSION

#13 | 2011-12-08

US20110301079A1

Chemistry; metallurgy

NEUROMEDIN U RECEPTOR AGONISTS AND USES THEREOF

#14 | 2011-07-28

US20110183902A1

Human necessities

Pharmaceutical composition comprising oxyntomodulin derivatives and a method for reducing body weight using the composition

#15 | 2011-02-24

US20110046056A1

Chemistry; metallurgy

APOA-1 PEPTIDE MIMETICS

#16 | 2010-12-02

US20100305028A1

Chemistry; metallurgy

Cholesterol derivatives of inhibitors of viral fusion

#17 | 2010-06-10

US20100144617A1

Human necessities

Pharmaceutical composition comprising oxyntomodulin derivatives and a method for reducing body weight using the composition

#18 | 2010-04-15

US20100092505A1

Chemistry; metallurgy

Method for Shielding Functional Sites or Epitopes on Proteins

#19 | 2010-03-25

US20100075907A1

Chemistry; metallurgy

NEUROMEDIN U RECEPTOR AGONISTS AND USES THEREOF

#20 | 2009-04-23

US20090104220A1

Chemistry; metallurgy

Method to Make a Peptide-Carrier Conjugate with a High Immunogenicity

#21 | 2007-10-18

US20070244048A1

Chemistry; metallurgy

Neuromedin U receptor agonists and uses thereof

#22 | 2007-09-27

US20070224212A1

Chemistry; metallurgy

Covalently stabilized chimeric coiled-coil HIV gp41 N-peptides with improved antiviral activity

#23 | 2006-02-07

US10129421

HCV NS3 protease inhibitors

InventorID:

712902 ⎘